Connor, Clark & Lunn Investment Management (CC&L)
OLMA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Olema Pharmaceuticals OLMA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
+70,711
New +$1.57M ﹤0.01% 1145
2024
Q3 		– Sell
-28,167
Closed -$305K – 1585
2024
Q2 		$305K Sell
28,167
-23,755
-46% -$258K ﹤0.01% 1183
2024
Q1 		$588K Buy
+51,922
New +$670K ﹤0.01% 1056

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s OLMA Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 70,711 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #1145 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in OLMA as recently as Q2 2024.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OLMA in Q1 2024 and has held it in 3 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 70,711 shares of Olema Pharmaceuticals worth $1.05M as of Q1 2026.
  • Olema Pharmaceuticals was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1145 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.